cd14 primary antibody Search Results


cd14 antibody (m5e2) - bsa free  (Bio-Techne corporation)
90
Bio-Techne corporation cd14 antibody (m5e2) - bsa free
Cd14 Antibody (M5e2) Bsa Free, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd14+primary+antibody/bio-techne+corporation___nb100-77758?v=Bio-Techne+corporation
Average 90 stars, based on 1 article reviews
cd14 antibody (m5e2) - bsa free - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
anti-human cd14 primary antibody li starfish  (Li StarFish srl)
90
Li StarFish srl anti-human cd14 primary antibody li starfish
HSV-2 ability to infect human monocyte cell line U937 relies on their differentiation level . A) HSV-2 replication in undifferentiated U937 cells. The U937 cell line was infected with two different MOI of HSV-2, as reported in the graph legend. Vero cells were infected as a control. HSV-2 titre in the cellular supernatants was measured by plaque assay, at different times post-infection (p.i.). B) Effect of TPA treatment of U937 cells on <t>CD14</t> expression. The effect of TPA treatment on U937 cell differentiation state was analyzed by CD14 FACS analysis. The percentage of positive cells is reported. C) HSV-2 replication in TPA-treated U937 cells. Undifferentiated or TPA-treated U937 cells were infected with HSV-2 (MOI of 1 PFU/cell). HSV-2 titre in the cellular supernatant was measured by plaque assay. In all cases, the reported values represent the mean of four independent experiments. The error bars represent the standard deviation.
Anti Human Cd14 Primary Antibody Li Starfish, supplied by Li StarFish srl, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd14+primary+antibody/pmc03083365-24-22-26?v=Li+StarFish+srl
Average 90 stars, based on 1 article reviews
anti-human cd14 primary antibody li starfish - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
primary antibody against cd14  (EnoGene Inc)
90
EnoGene Inc primary antibody against cd14
HSV-2 ability to infect human monocyte cell line U937 relies on their differentiation level . A) HSV-2 replication in undifferentiated U937 cells. The U937 cell line was infected with two different MOI of HSV-2, as reported in the graph legend. Vero cells were infected as a control. HSV-2 titre in the cellular supernatants was measured by plaque assay, at different times post-infection (p.i.). B) Effect of TPA treatment of U937 cells on <t>CD14</t> expression. The effect of TPA treatment on U937 cell differentiation state was analyzed by CD14 FACS analysis. The percentage of positive cells is reported. C) HSV-2 replication in TPA-treated U937 cells. Undifferentiated or TPA-treated U937 cells were infected with HSV-2 (MOI of 1 PFU/cell). HSV-2 titre in the cellular supernatant was measured by plaque assay. In all cases, the reported values represent the mean of four independent experiments. The error bars represent the standard deviation.
Primary Antibody Against Cd14, supplied by EnoGene Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd14+primary+antibody/10__14336_slash_ad__2018__1027-52-0-7?v=EnoGene+Inc
Average 90 stars, based on 1 article reviews
primary antibody against cd14 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
primary antibodies against cd14  (Bio SB Inc)
90
Bio SB Inc primary antibodies against cd14
HSV-2 ability to infect human monocyte cell line U937 relies on their differentiation level . A) HSV-2 replication in undifferentiated U937 cells. The U937 cell line was infected with two different MOI of HSV-2, as reported in the graph legend. Vero cells were infected as a control. HSV-2 titre in the cellular supernatants was measured by plaque assay, at different times post-infection (p.i.). B) Effect of TPA treatment of U937 cells on <t>CD14</t> expression. The effect of TPA treatment on U937 cell differentiation state was analyzed by CD14 FACS analysis. The percentage of positive cells is reported. C) HSV-2 replication in TPA-treated U937 cells. Undifferentiated or TPA-treated U937 cells were infected with HSV-2 (MOI of 1 PFU/cell). HSV-2 titre in the cellular supernatant was measured by plaque assay. In all cases, the reported values represent the mean of four independent experiments. The error bars represent the standard deviation.
Primary Antibodies Against Cd14, supplied by Bio SB Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd14+primary+antibody/pmc04878325-83-9-11?v=Bio+SB+Inc
Average 90 stars, based on 1 article reviews
primary antibodies against cd14 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


HSV-2 ability to infect human monocyte cell line U937 relies on their differentiation level . A) HSV-2 replication in undifferentiated U937 cells. The U937 cell line was infected with two different MOI of HSV-2, as reported in the graph legend. Vero cells were infected as a control. HSV-2 titre in the cellular supernatants was measured by plaque assay, at different times post-infection (p.i.). B) Effect of TPA treatment of U937 cells on CD14 expression. The effect of TPA treatment on U937 cell differentiation state was analyzed by CD14 FACS analysis. The percentage of positive cells is reported. C) HSV-2 replication in TPA-treated U937 cells. Undifferentiated or TPA-treated U937 cells were infected with HSV-2 (MOI of 1 PFU/cell). HSV-2 titre in the cellular supernatant was measured by plaque assay. In all cases, the reported values represent the mean of four independent experiments. The error bars represent the standard deviation.

Journal: Virology Journal

Article Title: Herpes simplex virus type 2 infection increases human immunodeficiency virus type 1 entry into human primary macrophages

doi: 10.1186/1743-422X-8-166

Figure Lengend Snippet: HSV-2 ability to infect human monocyte cell line U937 relies on their differentiation level . A) HSV-2 replication in undifferentiated U937 cells. The U937 cell line was infected with two different MOI of HSV-2, as reported in the graph legend. Vero cells were infected as a control. HSV-2 titre in the cellular supernatants was measured by plaque assay, at different times post-infection (p.i.). B) Effect of TPA treatment of U937 cells on CD14 expression. The effect of TPA treatment on U937 cell differentiation state was analyzed by CD14 FACS analysis. The percentage of positive cells is reported. C) HSV-2 replication in TPA-treated U937 cells. Undifferentiated or TPA-treated U937 cells were infected with HSV-2 (MOI of 1 PFU/cell). HSV-2 titre in the cellular supernatant was measured by plaque assay. In all cases, the reported values represent the mean of four independent experiments. The error bars represent the standard deviation.

Article Snippet: Briefly, 1 × 10 6 cells were harvested and directly incubated for one hour in cold PBS containing 1:100 (v/v) of an anti-human CD14 primary antibody (Li StarFISH).

Techniques: Infection, Control, Plaque Assay, Expressing, Cell Differentiation, Standard Deviation